Gyre Therapeutics

Catalyst Biosciences is a drug research and development company. The company is developing novel catalytic biopharmaceutical products based on engineered human proteases. Its mission is to establish protease therapy as a new therapeutic platform, comparable in depth and breadth to antibody drugs. The company is developing proteases for the treatment of various diseases, with a focus on hemostasis and inflammation.